- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
147 Clinical Paid Trials near Connecticut
Power is an online platform that helps thousands of patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerAutologous Cell Therapy for Critical Limb Ischemia
Trial Details
Key Eligibility Criteria
40 Participants Needed
ASTX660 for Cancer
Trial Details
Key Eligibility Criteria
230 Participants Needed
N-acetylcysteine for Lupus
Trial Details
Key Eligibility Criteria
290 Participants Needed
AVZO-023 for Breast Cancer
Trial Details
Key Eligibility Criteria
380 Participants Needed
Mezigdomide + Elranatamab for Multiple Myeloma
Trial Details
Key Eligibility Criteria
62 Participants Needed
ERAS-601 for Chordoma
Trial Details
Key Eligibility Criteria
10 Participants Needed
RO7446603 + Aflibercept/Faricimab for Diabetic Macular Edema
Trial Details
Key Eligibility Criteria
546 Participants Needed
Mirdametinib + Palbociclib for Liposarcoma
Trial Details
Key Eligibility Criteria
54 Participants Needed
Abemaciclib + Cabozantinib for Kidney Cancer
Trial Details
Key Eligibility Criteria
43 Participants Needed
Flu and COVID-19 Vaccines for Coronavirus and Influenza
Trial Details
Key Eligibility Criteria
2645 Participants Needed
Ruxolitinib + Ulixertinib for Myelofibrosis
Trial Details
Key Eligibility Criteria
37 Participants Needed
BEAM-301 for Glycogen Storage Disease
Trial Details
Key Eligibility Criteria
36 Participants Needed
Flu and COVID-19 Vaccines for Virus Protection
Trial Details
Key Eligibility Criteria
1353 Participants Needed
Guselkumab for Benign Familial Pemphigus
Trial Details
Key Eligibility Criteria
10 Participants Needed
REGN10597 for Solid Tumors
Trial Details
Key Eligibility Criteria
150 Participants Needed
Zilovertamab Vedotin for Pediatric and Young Adult Cancers
Trial Details
Key Eligibility Criteria
90 Participants Needed
GEN1055 + Pembrolizumab for Cancer
Trial Details
Key Eligibility Criteria
21 Participants Needed
Amivantamab Combinations for Head and Neck Cancer
Trial Details
Key Eligibility Criteria
247 Participants Needed
Gene Therapy for Hemophilia B
Trial Details
Key Eligibility Criteria
130 Participants Needed
IPN01194 for Cancer
Trial Details
Key Eligibility Criteria
220 Participants Needed
Why Other Patients Applied
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
IMP1734 for Advanced Solid Tumors
Trial Details
Key Eligibility Criteria
70 Participants Needed
Iberdomide + Belantamab Mafodotin + Dexamethasone for Multiple Myeloma
Trial Details
Key Eligibility Criteria
88 Participants Needed
Vepdegestrant + PF-07220060 for Breast Cancer
Trial Details
Key Eligibility Criteria
65 Participants Needed
BI-1910 + Pembrolizumab for Solid Tumors
Trial Details
Key Eligibility Criteria
104 Participants Needed
Vudalimab or Pembrolizumab with Chemotherapy for Lung Cancer
Trial Details
Key Eligibility Criteria
168 Participants Needed
AZD3470 for Advanced Solid Cancers
Trial Details
Key Eligibility Criteria
234 Participants Needed
Vepdegestrant + Samuraciclib for Advanced Breast Cancer
Trial Details
Key Eligibility Criteria
11 Participants Needed
mRNA Vaccines for Lyme Disease
Trial Details
Key Eligibility Criteria
807 Participants Needed
FOG-001 for Cancer
Trial Details
Key Eligibility Criteria
480 Participants Needed
Immunotherapy for Liver Cancer
Trial Details
Key Eligibility Criteria
62 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do clinical trials in Connecticut pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do clinical trials in Connecticut work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across trials in Connecticut 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Connecticut is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Connecticut several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a medical study in Connecticut?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest clinical trials in Connecticut?
Most recently, we added THC for Cognitive Function, Drug Combinations for Breast Cancer and Mezigdomide + Elranatamab for Multiple Myeloma to the Power online platform.